Last reviewed · How we verify
NCT05585879
Demonstrating Effective Salvage of Inadequate Colonoscopies
NA trial testing Pure-Vu EVS in Colorectal Screening in 16 participants. Terminated before completion.
26 April 2024
Quick facts
| Lead sponsor | Motus GI Medical Technologies Ltd |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 16 |
| Start date | 3 November 2022 |
| Primary completion | 26 April 2024 |
| Estimated completion | 26 April 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Pure-Vu EVS
Conditions studied
- Colorectal Screening — all drugs for Colorectal Screening →
Sponsor
Motus GI Medical Technologies Ltd
Who can join
Adults 40 to 80, any sex, with Colorectal Screening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to demonstrate that the use of the Pure-Vu EVS System can salvage inadequately prepared optical colonoscopies (OCs) to adequate OCs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05585879
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Motus GI Medical Technologies Ltd trials
Trials by the same sponsor.
- NCT04285008 — Randomized Controlled Study Comparing Colon Evaluation With The Pure-Vu System To A Standard Colonoscopy In Patients Who · NA · withdrawn
- NCT03922906 — Evaluation of Bowel Cleansing Using the Pure-Vu System in Patients With History of Inadequate Bowel Preparation · NA · terminated
- NCT03503162 — Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System · NA · completed
- NCT03493009 — Optimizing the Preparation Regime Prior to Colonoscopy Procedure With Pure-Vu System · NA · withdrawn
- NCT03026075 — Evaluation of the Performance of the Motus Cleansing System (MCS) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05585879 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Motus GI Medical Technologies Ltd
- Last refreshed: 13 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05585879.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing